![]() |
市场调查报告书
商品编码
1716343
2032 年超音波电外科设备市场预测:按产品、类型、应用、最终用户、地区进行的全球分析Ultrasonic Electrosurgical Devices Market Forecasts to 2032 - Global Analysis By Product (Generators and Consumables), Type (High-intensity Focused Ultrasonic (HIFU) Ablators and Shock Wave Therapy Systems), Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球超音波电外科设备市场预计在 2025 年达到 42 亿美元,到 2032 年将达到 69 亿美元,预测期内的复合年增长率为 7.4%。
超音波电外科设备是一种先进的手术器械,利用高频超音波振动同时切割和凝固组织。这些装置将电能转化为机械能,在尖端产生快速振动并透过摩擦产生热量。这种热量可以有效地封闭血管,减少手术过程中的出血。与传统的电外科器械不同,超音波器械的操作温度较低,最大限度地减少了对周围组织的热损伤。由于其精确、高效和降低併发症风险,它被广泛应用于微创手术和腹腔镜手术。
根据美国癌症研究所的数据,2020 年美国将诊断出约 1,806,590 例新癌症病例。
微创手术需求不断成长
由于对精确度、更快的恢復时间和最小疤痕的需求不断增加,对微创手术的需求不断增长,从而推动了超音波电外科设备市场的发展。这些仪器能够以最小的热损伤实现精确的组织解剖和凝固,使其成为腹腔镜和机器人手术的理想选择。随着患者和医疗保健提供者对更快、更安全的手术的需求,超音波电外科设备的采用正在加速。这一趋势正在支持技术创新和市场成长,加强其在现代外科手术中的作用。
设备高成本
超音波电外科设备的高成本是市场成长的主要障碍,尤其是在医疗预算有限的新兴市场。这种先进的设备需要大量投资,因此小型医院和诊所难以负担。与采购、维护和培训相关的财务负担进一步阻碍了广泛采用。因此,对成本敏感的市场通常会选择更实惠的替代品,对超音波电外科设备的整体需求产生负面影响。
技术进步
技术进步透过提高手术的精度、安全性和效率,大大推动了超音波电外科设备市场的成长。即时回馈系统、小型化以及与机器人手术平台的整合等技术创新正在改善临床结果并扩大各个专业的应用。这些进步正在减少患者的康復时间和手术併发症,加速其在已开发市场和新兴市场的采用。因此,技术进步仍然是市场扩张和创新的关键催化剂。
严格的监管核准
严格的监管核准会延迟产品发布并增加开发成本,对超音波电外科设备市场产生不利影响。复杂而漫长的核准流程阻碍了创新和市场进入,特别是对于资源较少的小型製造商。这些规定也延长了产品上市时间,并限制了医疗保健提供者获得先进设备的机会。这反过来又抑制了市场成长,并影响了更新、更有效的手术技术的采用率。
COVID-19的影响
由于选择性手术的延迟和供应链中断,COVID-19 疫情超音波电外科设备市场产生了重大影响。由于医院优先治疗新冠肺炎患者,对手术设备的需求下降。然而,随着医疗体系的调整和恢復非紧急程序,市场逐渐復苏。疫情之后,人们对微创手术的关注度不断提高,也促使人们对超音波电外科设备的兴趣重新燃起,并推动其发展。
预计发电机部分将成为预测期内最大的部分
预计预测期内发电机部分将占据最大的市场占有率。此发生器提供射频能源,可切割、凝固和消融组织,同时最大限度地减少热损伤,提高手术精度。功率控制和可靠性的进步极大地提高了超音波电外科设备的有效性。随着医疗保健提供者寻求更高效、更安全的微创选择,对这些设备中先进发电机的需求只会增加。
预计在预测期内,妇科手术部分将以最高的复合年增长率成长。
由于子宫肌瘤、子宫内膜异位症和其他生殖健康问题病例的增加,妇科手术领域预计将在预测期内出现最高增长率,这反过来又增加了对先进外科手术干预的需求。超音波电外科设备失血量少、恢復快、手术精度高,是妇科手术的理想选择。人们越来越偏好在女性健康领域采用有效、微创的解决方案,这推动了全球医疗机构采用超音波技术。
在预测期内,由于手术技术的进步和对微创手术的需求不断增长,预计亚太地区将占据最大的市场占有率。医疗保健投资的增加、医疗旅游业的蓬勃发展以及老年人口的不断增长,正在刺激医院和诊所采用它们。这些仪器精度更高、失血量更少、恢復时间更快,改善了手术效果。一般外科、妇科外科和心血管外科的使用日益增长,推动着市场的发展,提高了全部区域的医疗效率和患者照护。
预计北美地区在预测期内将呈现最高的复合年增长率。因为这些工具可以提高手术精确度、减少出血并促进更快康復,进而改善患者的治疗效果。医院和门诊手术中心采用该技术的原因是老年人口的增长和慢性病发病率的上升。北美凭藉其强大的医疗保健基础设施和持续的研发支出,已成为全球手术设备进步的领先开发者和贡献者。
According to Stratistics MRC, the Global Ultrasonic Electrosurgical Devices Market is accounted for $4.2 billion in 2025 and is expected to reach $6.9 billion by 2032 growing at a CAGR of 7.4% during the forecast period. Ultrasonic electrosurgical devices are advanced surgical instruments that use high-frequency ultrasonic vibrations to cut and coagulate tissue simultaneously. These devices convert electrical energy into mechanical energy, generating rapid vibrations at the tip, which produces heat through friction. This heat effectively seals blood vessels and reduces bleeding during procedures. Unlike traditional electrosurgical tools, ultrasonic devices operate at lower temperatures, minimizing thermal damage to surrounding tissues. They are widely used in minimally invasive and laparoscopic surgeries due to their precision, efficiency, and reduced risk of complications.
According to National Cancer Institute, about 1,806,590 new cancer cases were diagnosed in the U.S. in 2020.
Rising Demand for Minimally Invasive Surgeries
The rising demand for minimally invasive surgeries is positively driving the ultrasonic electrosurgical devices market by increasing the need for precision, reduced recovery times, and minimal scarring. These devices enable accurate tissue dissection and coagulation with minimal thermal damage, making them ideal for laparoscopic and robotic surgeries. As patients and healthcare providers seek faster, safer procedures, the adoption of ultrasonic electrosurgical devices is accelerating. This trend supports innovation and market growth, reinforcing their role in modern surgical practices.
High Cost of Devices
The high cost of ultrasonic electrosurgical devices poses a significant barrier to market growth, particularly in developing regions with limited healthcare budgets. These advanced devices require substantial investment, making them less accessible for smaller hospitals and clinics. The financial burden associated with procurement, maintenance, and training further hinders widespread adoption. As a result, cost-sensitive markets often opt for more affordable alternatives, negatively affecting the overall demand for ultrasonic electrosurgical devices.
Technological Advancements
Technological advancements are significantly driving the growth of the ultrasonic electrosurgical devices market by enhancing precision, safety, and efficiency in surgical procedures. Innovations such as real-time feedback systems, miniaturization, and integration with robotic surgery platforms have improved clinical outcomes and expanded applications across various specialties. These advancements reduce patient recovery time and surgical complications, boosting their adoption in both developed and emerging healthcare markets. As a result, technological progress continues to be a key catalyst for market expansion and innovation.
Stringent Regulatory Approvals
Stringent regulatory approvals have negatively impacted the ultrasonic electrosurgical devices market by delaying product launches and increasing development costs. Complex and lengthy approval processes hinder innovation and market entry, particularly for smaller manufacturers lacking extensive resources. These regulations also contribute to extended time-to-market, limiting the availability of advanced devices to healthcare providers. As a result, market growth is constrained, affecting the adoption rate of newer, more efficient surgical technologies.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the ultrasonic electrosurgical devices market due to the postponement of elective surgeries and disruptions in supply chains. Hospitals prioritized COVID-19 treatment, leading to reduced demand for surgical devices. However, the market gradually recovered as healthcare systems adapted and resumed non-emergency procedures. Increased focus on minimally invasive surgeries post-pandemic has also contributed to renewed interest and growth in ultrasonic electrosurgical devices.
The generators segment is expected to be the largest during the forecast period
The generators segment is expected to account for the largest market share during the forecast period, as these generators offer high-frequency energy that enables tissue cutting, coagulation, and ablation with minimal thermal damage, enhancing surgical precision. Their advancement in terms of power control and reliability has significantly improved the effectiveness of ultrasonic electrosurgical devices. As healthcare providers seek more efficient, safer, and minimally invasive options, the demand for advanced generators in these devices continues to rise.
The gynecological surgery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the gynecological surgery segment is predicted to witness the highest growth rate, as increasing cases of uterine fibroids, endometriosis, and other reproductive health issues have heightened the need for advanced surgical interventions. Ultrasonic electrosurgical devices offer reduced blood loss, quicker recovery, and enhanced surgical accuracy, making them ideal for gynecological procedures. This growing preference for effective, less invasive solutions in women's health is significantly boosting the adoption of ultrasonic technologies across healthcare facilities worldwide.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to advancements in surgical technology and rising demand for minimally invasive procedures. Increasing healthcare investments, growing medical tourism, and a rising geriatric population are fueling adoption across hospitals and clinics. These devices offer greater precision, reduced blood loss, and faster recovery times, improving surgical outcomes. Their expanding use in general, gynecological, and cardiovascular surgeries is driving market momentum, enhancing overall healthcare efficiency and patient care across the region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, because these tools improve patient outcomes by increasing surgical precision, minimizing blood loss, and encouraging quicker recovery. Adoption in hospitals and ambulatory surgery centers is being fueled by the growing geriatric population and the rising frequency of chronic diseases. North America is establishing itself as a major developer and contributor to the progress of surgical devices worldwide due to its robust healthcare infrastructure and continuous R&D spending.
Key players in the market
Some of the key players profiled in the Ultrasonic Electrosurgical Devices Market include Medtronic, Johnson & Johnson, Olympus Corporation, Boston Scientific Corporation, BOWA-electronic GmbH & Co. KG, Advanced Instrumentations, Soring GmbH, Italia Medica, Reach Surgical, Sonablate, Miconvey, Silfradent, Alfa Medtech, CONMED Corporation, B. Braun Melsungen AG, Medisafe International, Shantou Institute of Ultrasonic Instruments Co., Ltd. and Insightec.
In October 2024, Royal Philips and Medtronic Neurovascular announced a strategic advocacy partnership aimed at accelerating access to life-saving stroke treatments globally. Both companies also joined the newly established World Stroke Organization (WSO) Advocacy Coalition.
In September 2024, Medtronic and Sunway Healthcare Group have expanded their strategic partnership through a Memorandum of Understanding (MoU) aimed at advancing specialized medical care in Malaysia. The collaboration focuses on enhancing the Centres of Excellence at Sunway Medical Centre in Subang Jaya, particularly in spine, neuroscience, and cardiovascular medicine.
In August 2024, Abbott and Medtronic have announced a strategic partnership to develop an integrated diabetes management system that combines Abbott's continuous glucose monitoring (CGM) technology with Medtronic's insulin delivery devices.